On May 16, 2023 Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, reported that George Buchman, Ph.D., Vice President, Pre-Clinical and Process Development, will present at the upcoming 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) (Free ASGCT Whitepaper), which is being held at the Los Angeles Convention Center on May 16-20, 2023 (Press release, Catalent, MAY 16, 2023, https://www.catalent.com/catalent-news/catalent-to-present-on-integrated-uptempo-gene-therapy-development-platform/ [SID1234631769]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Dr. Buchman’s presentation, on Friday, May 19, at 4:30 p.m. PDT, is entitled "One-stop Integrated Viral Vector Platform for Speed to Clinic," and will focus on a consolidated and standardized platform to help fast-track AAV vectors to the clinic with a scalable CGMP-ready process. The complete UpTempo℠ AAV platform, which was re-launched in its expanded form in March 2023, provides increased consistency and efficiency, reducing the time to manufacture clinical-quality drug product to just nine months, while delivering a process that will readily advance to late-stage CGMP manufacture.
Dr. Buchman works in Catalent’s Cell & Gene Therapy business, which provides research services and process development and enables the translation of programs into clinical trials and commercial CGMP manufacturing. He has worked more than 30 years in the biotech industry, including at Life Technologies (now Thermo Fisher Scientific), Celera Genomics, and GeneLogic. Dr. Buchman obtained his bachelor’s degree in biochemistry from Albright College, Reading, Pennsylvania, and his doctorate in biochemistry from the University of Maryland.
Catalent will also be exhibiting at the conference, in booth 229. To find out more information about this event, visit https://www.catalent.com/events/asgct-annual-meeting-2023/ and to find out more about Catalent’s UpTempo AAV platform, visit Catalent.com/UpTempo.